Skip to main content

Peer Review reports

From: Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial

Original Submission
28 Mar 2022 Submitted Original manuscript
18 Apr 2022 Reviewed Reviewer Report
22 Apr 2022 Reviewed Reviewer Report
21 May 2022 Author responded Author comments - Xin Xu
Resubmission - Version 2
21 May 2022 Submitted Manuscript version 2
12 Jun 2022 Reviewed Reviewer Report
13 Jun 2022 Reviewed Reviewer Report
9 Jul 2022 Author responded Author comments - Xin Xu
Resubmission - Version 3
9 Jul 2022 Submitted Manuscript version 3
Publishing
14 Jul 2022 Editorially accepted
2 Sep 2022 Article published 10.1186/s12916-022-02479-x

You can find further information about peer review here.

Back to article page